Cedar Brook Financial Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $216K | Sell |
|
|||||
|
2024
Q1 | $841K | Sell |
|
|||||
|
2023
Q4 | $863K | Sell |
|
|||||
|
2023
Q3 | $887K | Buy |
|
|||||
|
2023
Q2 | $931K | Sell |
|
|||||
|
2023
Q1 | $944K | Buy |
|
|||||
|
2022
Q4 | $898K | Buy |
|
|||||
|
2022
Q3 | $658K | Buy |
|
|||||
|
2022
Q2 | $724K | Sell |
|
|||||
|
2022
Q1 | $764K | Buy |
|
|||||
|
2021
Q4 | $653K | Buy |
|
|||||
|
2021
Q3 | $653K | Buy |
|
|||||
|
2021
Q2 | $611K | Buy |
|
|||||
|
2021
Q1 | $467K | Buy |
|
|||||
|
2020
Q4 | $409K | Buy |
|
|||||
|
2020
Q3 | $392K | Buy |
|
|||||
|
2020
Q2 | $373K | Sell |
|
|||||
|
2020
Q1 | $321K | Sell |
|
|||||
|
2019
Q4 | $380K | Sell |
|
|||||
|
2019
Q3 | $347K | Buy |
|
|||||
|
2019
Q2 | $285K | Buy |
|
|||||
|
2019
Q1 | $269K | Buy |
|